Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7Stomach Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neutropenia 1Neoplasm Metastasis 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1EFS 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Anal Cancer Metastatic 1Advanced Solid Tumors 1Advanced Colorectal Cancer 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

trifluridine tipiracil drug combination 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × EFS × trifluridine tipiracil drug combination × Clear all
NCT07090031 2025-07-29

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Qingdao Central Hospital

Phase 2 Active not recruiting
49 enrolled

EFS

Data powered by HemOnc (CC BY 4.0) Colophon âš¡